-
Advancing Prognostic Assessment in Pediatric Acute Myeloid Leukemia with KMT2A Rearrangement: Integrating Transcriptomic Profiling
In November 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——Hemasphere. The title of the study is “Integration of Transcriptomic Features to Improve Prognosis Prediction of Pediatric Acute Myeloid Leukemia With…
-
Establishment of a Prognostic Model and Tumor Clustering for Pediatric Acute Myeloid Leukemia Patients: Leveraging the Fanconi Anemia Signaling Pathway to Enhance Clinical Management
In November 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——Open Medicine(Wars). The title of the study is “Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for…
-
Long-Term Outcome of Rabbit Anti-Thymocyte Globulin and Cyclosporine Therapy for Pediatric Severe Aplastic Anemia
In May 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——Blood Science. The title of the study is “An investigation of long-term outcome of rabbit anti-thymocyte globulin and cyclosporine therapy for…
-
Acinetobacter spp. Bloodstream Infection in Hematological Patients: A 10-Year Single-Center Study
In November 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——BMC Infectious Diseases. The title of the study is “Acinetobacter spp. Bloodstream Infection in Hematological Patients: A 10-Year Single-Center Study”. This…
-
Revolutionizing AAV Neutralizing Antibody Detection with CRISPR-Cas9 Technology
Editor’s note: Adeno-associated virus (AAV) vector gene therapy holds immense potential for treating genetic disorders. However, the presence of AAV-neutralizing antibodies (NAbs) can hamper its effectiveness. Accurate detection of these…
-
Unraveling the Complexity of Acute Myeloid Leukemia: Insights from Single-Cell Analysis
In November 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——BMC Bioinformatics. The title of the study is “Detection of continuous hierarchical heterogeneity by single-cell surface antigen analysis in the prognosis evaluation of acute myeloid leukaemia”.…
-
Enhancing Early Infection Risk Prediction in Newly Diagnosed Multiple Myeloma: A Nomogram Prognostic Model Approach
Editor’s note: In patients with newly diagnosed multiple myeloma (NDMM), infections pose a significant threat to morbidity and mortality, particularly within the initial months post-diagnosis. Immunoparesis, characterized by reduced levels…
-
Dr.Yanhang Gao’s Team: Non-Invasive Screening for ANA-Positive DILI Patients with AIH-Like Histological Features, Aiding in Precise Liver Biopsy!
Drug-induced liver injury (DILI) can mimic all features of acute and chronic liver diseases, including autoimmune hepatitis (AIH). Both conditions exhibit similarities in serology and histology, including the presence of…
Connecting Medical Expertise through Media